Drug
Incb099318
Incb099318: highest development phase Phase 1, developed by Incyte. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Incyte
Trials
| Drug | Phase | Indication |
|---|---|---|
| INCB099318 NCT04272034 | Phase 1 | Advanced Solid Tumors |
Latest
No recent events.
Follow Incb099318 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.